Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2013

01.07.2013 | Original Research

Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome

verfasst von: Alexandra F. Freeman, Ellen D. Renner, Carolyn Henderson, Anne Langenbeck, Kenneth N. Olivier, Amy P. Hsu, Beate Hagl, Annette Boos, Joie Davis, Beatriz E. Marciano, Lisa Boris, Pamela Welch, Julie Sawalle-Belohradsky, Bernd H. Belohradsky, King F. Kwong, Steven M. Holland

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Autosomal dominant hyper-IgE syndrome (AD-HIES) due to heterozygous STAT3 mutation is a primary immunodeficiency characterized by eczema, elevated serum IgE, recurrent infections, and connective tissue and skeletal findings. Healing of pneumonias is often abnormal with formation of pneumatoceles and bronchiectasis. We aimed to explore whether healing after lung surgery is also aberrant.

Methods

We retrospectively analyzed the medical records of 32 patients with AD-HIES who received lung surgery for the management of pulmonary infections from 1960 to 2011. We collected information including patient demographics, STAT3 mutation status, clinical history, surgical and medical procedures performed, complications, related medical treatments, and outcomes.

Results

More than 50 % of lung surgeries had associated complications, with the majority being prolonged bronchopleural fistulae. These fistulae often led to empyemas that necessitated additional interventions including prolonged antibiotics, prolonged thoracostomy tube drainage and re-operations.

Conclusion

Lung surgery in AD-HIES patients is associated with high complication rates. STAT3 mutations likely lead to abnormalities in tissue remodelling that are further exacerbated by infection.
Literatur
1.
Zurück zum Zitat Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19.PubMedCrossRef Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19.PubMedCrossRef
2.
Zurück zum Zitat Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMedCrossRef Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMedCrossRef
3.
Zurück zum Zitat Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32.PubMedCrossRef Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32.PubMedCrossRef
4.
Zurück zum Zitat Chandesris M, Melki I, Natividad A, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91:e1–e19.PubMedCrossRef Chandesris M, Melki I, Natividad A, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91:e1–e19.PubMedCrossRef
5.
Zurück zum Zitat Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–40.PubMedCrossRef Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–40.PubMedCrossRef
6.
Zurück zum Zitat Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:617–8.PubMedCrossRef Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:617–8.PubMedCrossRef
7.
Zurück zum Zitat Vinh DC, Sugui JA, Hsu AP, et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:1389–90.PubMedCrossRef Vinh DC, Sugui JA, Hsu AP, et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:1389–90.PubMedCrossRef
8.
Zurück zum Zitat Grimbacher B, Schaffer A, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.PubMedCrossRef Grimbacher B, Schaffer A, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.PubMedCrossRef
9.
Zurück zum Zitat Schimke LF, Sawalle-Belohradsky J, Roesler J, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.e.1.PubMedCrossRef Schimke LF, Sawalle-Belohradsky J, Roesler J, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.e.1.PubMedCrossRef
10.
Zurück zum Zitat Heimall J, Davis J, Shaw PA, et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE syndrome (HIES). Clin Immunol. 2011;139:75–84.PubMedCrossRef Heimall J, Davis J, Shaw PA, et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE syndrome (HIES). Clin Immunol. 2011;139:75–84.PubMedCrossRef
11.
Zurück zum Zitat Sagan D, Gozdziuk K, Korobowicz E. Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma. J Surg Res. 2010;163:e35–43.PubMedCrossRef Sagan D, Gozdziuk K, Korobowicz E. Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma. J Surg Res. 2010;163:e35–43.PubMedCrossRef
12.
Zurück zum Zitat Sagan D, Gozdziuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg. 2010;89:1603–10.PubMedCrossRef Sagan D, Gozdziuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg. 2010;89:1603–10.PubMedCrossRef
13.
Zurück zum Zitat Sekhsaria V, Dodd LE, Hsu AP. Plasma metalloproteinase levels are dysregulated in signal transduction and transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128:1124–7.PubMedCrossRef Sekhsaria V, Dodd LE, Hsu AP. Plasma metalloproteinase levels are dysregulated in signal transduction and transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128:1124–7.PubMedCrossRef
14.
Zurück zum Zitat Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715–31.PubMedCrossRef Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715–31.PubMedCrossRef
15.
Zurück zum Zitat Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48:440–4.PubMedCrossRef Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48:440–4.PubMedCrossRef
16.
Zurück zum Zitat Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol. 2008;172:1542–54.PubMedCrossRef Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol. 2008;172:1542–54.PubMedCrossRef
17.
Zurück zum Zitat Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;126:392–4.PubMedCrossRef Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;126:392–4.PubMedCrossRef
Metadaten
Titel
Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome
verfasst von
Alexandra F. Freeman
Ellen D. Renner
Carolyn Henderson
Anne Langenbeck
Kenneth N. Olivier
Amy P. Hsu
Beate Hagl
Annette Boos
Joie Davis
Beatriz E. Marciano
Lisa Boris
Pamela Welch
Julie Sawalle-Belohradsky
Bernd H. Belohradsky
King F. Kwong
Steven M. Holland
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2013
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9890-5

Weitere Artikel der Ausgabe 5/2013

Journal of Clinical Immunology 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.